Literature DB >> 2157185

Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.

F Theuring1, W Götz, R Balling, H W Korf, F Schulze, R Herken, P Gruss.   

Abstract

Transgenic mice which expressed SV40 large T-antigen under the control of the MSV enhancer and the SV40 promoter were generated. In animals containing an intact MSV enhancer, total lens cataracts and neuroectodermal brain tumors, originating in the pineal organ were observed. In contrast, 5' deletion of the MSV enhancer to a residual 53 bp resulted in a different spectrum of pathologies. Whilst lens cataracts still occurred, no brain tumors could be detected. Instead, fibrosarcomas and adenocarcinomas of the kidneys were induced. In addition, tumors of the endocrine pancreas were observed with both transgene constructs. We conclude that the MSV enhancer element is sufficient to direct the expression of the viral reporter gene to the lens and the pineal organ in transgenic mice. Deletion of the MSV enhancer correlates with the loss of DNA elements responsible for the pineal cell specific expression of SV40 large T-antigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157185

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

Review 1.  Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System.

Authors:  Annamaria Brändli-Baiocco; Emmanuelle Balme; Marc Bruder; Sundeep Chandra; Juergen Hellmann; Mark J Hoenerhoff; Takahito Kambara; Christian Landes; Barbara Lenz; Mark Mense; Susanne Rittinghausen; Hiroshi Satoh; Frédéric Schorsch; Frank Seeliger; Takuji Tanaka; Minoru Tsuchitani; Zbigniew Wojcinski; Thomas J Rosol
Journal:  J Toxicol Pathol       Date:  2018-07-28       Impact factor: 1.628

2.  Melanosis and associated tumors in transgenic mice.

Authors:  A Klein-Szanto; M Bradl; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

3.  Expression of the rasT24 oncogene in the ciliary body pigment epithelium and retinal pigment epithelium results in hyperplasia, adenoma, and adenocarcinoma.

Authors:  P Chévez-Barrios; D L Schaffner; R Barrios; P A Overbeek; R M Lebovitz; M W Lieberman
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

Review 4.  Murine models of neoplasia: functional analysis of the tumour suppressor genes Rb-1 and p53.

Authors:  A R Clarke
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

5.  Midline brain tumors in MSV-SV 40-transgenic mice originate from the pineal organ.

Authors:  W Götz; F Theuring; W Schachenmayr; H W Korf
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  Cell-type specific interaction of endothelin and the nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic mice.

Authors:  Torsten Slowinski; Philipp Kalk; Maren Christian; Fred Schmager; Katharina Relle; Michael Godes; Heiko Funke-Kaiser; Hans-H Neumayer; Christian Bauer; Franz Theuring; Berthold Hocher
Journal:  J Physiol       Date:  2007-03-29       Impact factor: 5.182

7.  A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen.

Authors:  R H Eibl; P Kleihues; P S Jat; O D Wiestler
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

8.  Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.

Authors:  W Götz; C Schucht; J Roth; F Theuring; R Herken
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs.

Authors:  J M Arbeit; K Münger; P M Howley; D Hanahan
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

10.  Expression of bovine myf5 induces ectopic skeletal muscle formation in transgenic mice.

Authors:  R F Santerre; K R Bales; M J Janney; K Hannon; L F Fisher; C S Bailey; J Morris; R Ivarie; C K Smith
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.